Department of Cardiac, Thoracic and Vascular Surgery, National University Heart Centre Singapore, Singapore.
Asian Cardiovasc Thorac Ann. 2021 Mar;29(3):165-169. doi: 10.1177/0218492320962932. Epub 2020 Sep 30.
Extracorporeal membrane oxygenation has been used for COVID-19 patients with refractory hypoxemia.
We share our institution's experience in organizing extracorporeal membrane oxygenation services in Singapore during the COVID-19 pandemic. We also share our first COVID-19 extracorporeal membrane oxygenation case report.
We encountered initial difficulties in providing extracorporeal membrane oxygenation services in Singapore in view of the considerations of managing COVID-19 patients. By adopting rigorous planning, patient selection, staff training, adhering to infection control measures and preparing transport essentials, we were able to reorganize the extracorporeal membrane oxygenation services to serve the nation's needs. This culminated in our first successful COVID-19 extracorporeal membrane oxygenation retrieval case.
Extracorporeal membrane oxygenation is an option for COVID-19 patients but preparation must be taken to prepare the extracorporeal membrane oxygenation teams to deal with this pandemic and future challenges.
体外膜肺氧合已被用于治疗 COVID-19 患者的难治性低氧血症。
我们分享了在 COVID-19 大流行期间，我们机构在新加坡组织体外膜肺氧合服务的经验。我们还分享了首例 COVID-19 体外膜肺氧合病例报告。
鉴于管理 COVID-19 患者的考虑因素，我们在新加坡最初提供体外膜肺氧合服务时遇到了困难。通过采取严格的规划、患者选择、员工培训、坚持感染控制措施和准备运输必需品，我们能够重新组织体外膜肺氧合服务以满足国家的需求。这最终促成了我们首例成功的 COVID-19 体外膜肺氧合检索病例。
体外膜肺氧合是 COVID-19 患者的一种选择，但必须做好准备，组建体外膜肺氧合团队，以应对这一大流行病和未来的挑战。
